1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T76944 | Cergutuzumab amunaleukin | ||
Cergutuzumab amunaleukin (CEA-IL2v), a monomeric immunocytokine, targets carcinoembryonic antigen (CEA) and is based on an IL-2 variant. It exhibits immunostimulating and antineoplastic activities. |